Colby Pharmaceutical and MannKind Corporation (MNKD) Sign License and Joint Development Agreement to Develop and Commercialize Cancer Immunotherapy Products
11/13/2012 9:32:17 AM
More...
|
Colby Pharmaceutical Announces SBIR Award for JunD Oncoprotein-Androgen Receptor (AR) Interaction Inhibitor Drugs in Novel Prostate Cancer Therapy
10/1/2012 10:08:12 AM
More...
|
Colby Pharmaceutical Acquires Othera Pharmaceuticals
9/19/2012 10:08:08 AM
More...
|
Colby Pharmaceutical Announces Publication of JVRS-100 use as Potent Immune Activating Adjuvant in Combination with H5N1 Influenza Vaccine
1/9/2012 6:05:23 AM
More...
|
Juvaris BioTherapeutics Announces License to Colby Pharmaceutical for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health
9/9/2011 10:40:05 AM
More...
|
Adamis Completes Acquisition of Prostate Drug Candidates from Colby Pharmaceutical
10/19/2010 11:23:36 AM
More...
|
Adamis Signs Agreement With Colby Pharmaceutical to Acquire Prostate Cancer Drug Candidates
2/25/2010 10:47:27 AM
More...
|